Jabra Enhance Select 200 vs ReSound OMNIA RIE
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.

ReSound OMNIA RIE
The ReSound OMNIA RIE is a premium prescription behind-the-ear hearing aid released in 2022, currently available at $4,498. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.9/5, ranking #31 of 39 devices in the prescription hearing aid category. This device shows notable strengths in speech clarity for quiet environments, scoring 3.7/5—a solid result that sits 0.34 points above the category average. Own-voice comfort also performs above average at 3.0/5, which may appeal to users who find their own voice bothersome in other devices. Feedback handling is strong in absolute terms at 4.1/5, though it falls 0.62 points below the category average of 4.72/5. The OMNIA RIE's most significant limitation is speech in noise performance, scoring just 1.0/5—a low result that trails the category average by 1.11 points. For users who frequently encounter challenging listening environments like restaurants or group conversations, this represents a meaningful gap compared to alternatives. Music streaming scores a mixed 2.7/5, essentially matching the category average. The device offers flexible power options with both rechargeable and disposable batteries, plus streaming compatibility with iPhone and Android devices including hands-free functionality. However, at this premium price point, several competitors deliver stronger overall performance, including options from Phonak, Oticon, and Widex. The OMNIA RIE may suit users who prioritize quiet-environment clarity and own-voice comfort over noise-handling capabilities.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit